Bibliography
- NORMAN P: New approaches to asthma therapy: trends from the patent literature 1993-1997. Exp. Op/n. Then Patents (1997) 7:677–685.
- HANSON GJ: Inhibitors of p38 kinase. Exp. Op/n. Then Patents (1997) 7:729–734.
- MCKINNON M, PROUDFOOT AEI, WELLS TNC, SOLARI R: Strategies for the discovery of cytokine and che-mokine receptor antagonists. Drug News Perspect. (1996) 9:389–398.
- MAESEN FP, SMEETS JJ, SLEDSENS TJ, WALD FD, COR-NELISSEN PJ: Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur. Resp. J. (1995) 8:1506–1513.
- MARTEL AM, RABESSEDA X, CASTANER J: Revatropate, UK112166. Drugs Fut. (1996) 22:135–137.
- BARKER AF: Alpha 1-antitrypsin-deficiency-related em-physema. J. Am. Board Earn. Pract. (1992) 5:489–493.
- EDWARDS PD, BERNSTEIN PR: Synthetic inhibitors of elastase. Med. Res. Rev. (1994) 14:127–194.
- EDWARDS PD, VEALE CA: Inhibitors of human neutro-phil elastase. Exp. Op/n. Then Patents (1997) 7:17–28.
- SNIDER GL, LUCEY EC, STONE PJ: Pitfalls in antiprotease therapy of emphysema. Am. J. Resp. Grit. Care Med. (1994) 150:S131–137.
- SHEPPARD DN, OSTEDGAARD LS: Understanding how cystic fibrosis mutations cause a loss of chloride chan-nel function. Mof Med. Today (1996) 2:290–297.
- WILSON JM: Gene therapy for cystic fibrosis: chal-lenges and future directions. J. Din. Invest. 96:2547-2554.
- VASCONCELLOS CA, ALLEN PG, WOHL ME et al.: Reduc-tion in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science (1994) 263:969–971.
- GRIBKOFF VK et al.: The substituted benzimidazolone N5004 is an opener of the cystic fibrosis chloride chan-nel. J. Biol. Chem. (1994) 269:19349–19353.
- KEHRER JP, MARGOLIN SB: Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice. Toxicol. Lett. (1997) 90:125–132.
- BERNARD GR, ARTIGAS A, BRIGHAM KL et al.: The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial co-ordination. Am. J. Resp. Grit. Care Med. (1994) 149:818–824.
- SCICLONE PHARMACEUTICALS: SciClone reports break-through preclinical discovery involving CPX at annual Cystic Fibrosis conference. Press Release (25 October 1997).